<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Vulvar Lesion Case – Teaching Webapp</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <style>
    :root {
      /* Typography */
      --root-font-size: 16px;
      --font-family-main: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;

      /* Light theme (default) */
      --bg: #f7f7fb;
      --card-bg: #ffffff;
      --accent: #324b7a;
      --accent-soft: #e0e6f4;
      --text-main: #222222;
      --text-muted: #666666;
      --border-soft: #e0e0e0;
      --danger: #b00020;
    }

    /* Dark theme overrides */
    body.dark {
      --bg: #020617;
      --card-bg: #020617;
      --accent: #60a5fa;
      --accent-soft: #1f2937;
      --text-main: #e5e7eb;
      --text-muted: #9ca3af;
      --border-soft: #334155;
      --danger: #f97373;
    }

    html {
      font-size: var(--root-font-size);
    }

    * {
      box-sizing: border-box;
    }

    body {
      margin: 0;
      font-family: var(--font-family-main);
      background: var(--bg);
      color: var(--text-main);
    }

    /* Top navbar */
    header {
      position: sticky;
      top: 0;
      z-index: 100;
      background: #ffffffcc;
      backdrop-filter: blur(6px);
      border-bottom: 1px solid var(--border-soft);
    }

    body.dark header {
      background: #020617dd;
    }

    .nav-container {
      max-width: 1100px;
      margin: 0 auto;
      padding: 0.5rem 1rem;
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem 1rem;
      align-items: center;
    }

    .app-title {
      font-weight: 600;
      font-size: 1.05rem;
      color: var(--accent);
      white-space: nowrap;
    }

    .nav-controls {
      display: flex;
      flex-wrap: wrap;
      gap: 0.35rem;
      align-items: center;
      margin-left: auto;
    }

    .utility-button {
      border: 1px solid var(--border-soft);
      background: var(--card-bg);
      padding: 0.25rem 0.6rem;
      border-radius: 999px;
      font-size: 0.8rem;
      cursor: pointer;
      color: var(--text-muted);
    }

    .utility-button:hover {
      background: var(--accent-soft);
      color: var(--accent);
    }

    .nav-label {
      font-size: 0.75rem;
      color: var(--text-muted);
      display: inline-flex;
      align-items: center;
      gap: 0.25rem;
    }

    .nav-select {
      font-size: 0.78rem;
      padding: 0.15rem 0.4rem;
      border-radius: 999px;
      border: 1px solid var(--border-soft);
      background: var(--card-bg);
      color: var(--text-main);
    }

    nav.nav-links {
      display: flex;
      flex-wrap: wrap;
      gap: 0.35rem;
      margin-left: 0;
    }

    .nav-button {
      border: none;
      background: transparent;
      padding: 0.3rem 0.7rem;
      border-radius: 999px;
      font-size: 0.8rem;
      cursor: pointer;
      color: var(--text-muted);
      transition: background 0.15s ease, color 0.15s ease;
      white-space: nowrap;
    }

    .nav-button:hover {
      background: var(--accent-soft);
      color: var(--accent);
    }

    .nav-button.active {
      background: var(--accent);
      color: #ffffff;
    }

    main {
      max-width: 1100px;
      margin: 1rem auto 2.5rem;
      padding: 0 1rem;
    }

    .page {
      display: none;
      animation: fadeIn 0.15s ease-in;
      padding-top: 0.3rem;
    }

    .page.active {
      display: block;
    }

    @keyframes fadeIn {
      from { opacity: 0; transform: translateY(4px); }
      to { opacity: 1; transform: translateY(0); }
    }

    .card {
      background: var(--card-bg);
      border-radius: 12px;
      padding: 1.1rem 1.2rem;
      box-shadow: 0 1px 3px rgba(15, 23, 42, 0.08);
      border: 1px solid var(--border-soft);
      margin-bottom: 1.7rem; /* more space between blocks */
    }

    .card-header {
      display: flex;
      justify-content: space-between;
      align-items: baseline;
      gap: 0.75rem;
      margin-bottom: 0.6rem;
    }

    .card-title {
      font-size: 1.1rem;
      font-weight: 600;
      color: var(--accent);
    }

    .card-subtitle {
      font-size: 0.8rem;
      color: var(--text-muted);
    }

    h2 {
      font-size: 1.2rem;
      margin: 0 0 0.5rem;
      color: var(--accent);
    }

    h3 {
      font-size: 1.02rem;
      margin: 0.7rem 0 0.35rem;
    }

    p {
      margin: 0.45rem 0;
      line-height: 1.7;
      font-size: 0.95rem;
    }

    ul,
    ol {
      margin: 0.25rem 0 0.6rem 1.2rem;
      padding: 0;
      font-size: 0.9rem;
      line-height: 1.7;
    }

    .pill {
      display: inline-flex;
      align-items: center;
      gap: 0.25rem;
      padding: 0.15rem 0.55rem;
      border-radius: 999px;
      background: var(--accent-soft);
      font-size: 0.75rem;
      color: var(--accent);
      margin-right: 0.25rem;
      margin-bottom: 0.25rem;
    }

    .badge-danger {
      background: #fde4ea;
      color: var(--danger);
    }

    body.dark .badge-danger {
      background: #451924;
    }

    .grid-2 {
      display: grid;
      grid-template-columns: minmax(0, 1.2fr) minmax(0, 1fr);
      gap: 1.1rem;
    }

    .muted {
      color: var(--text-muted);
      font-size: 0.85rem;
    }

    .image-grid {
      display: grid;
      grid-template-columns: repeat(auto-fill, minmax(180px, 1fr));
      gap: 0.8rem;
      margin-top: 0.5rem;
    }

    .image-placeholder {
      border-radius: 10px;
      border: 1px dashed var(--border-soft);
      min-height: 120px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-size: 0.8rem;
      color: var(--text-muted);
      padding: 0.5rem;
      text-align: center;
    }

    .table-like {
      width: 100%;
      border-collapse: collapse;
      margin-top: 0.5rem;
      font-size: 0.9rem;
    }

    .table-like th,
    .table-like td {
      border: 1px solid var(--border-soft);
      padding: 0.5rem 0.6rem;
      vertical-align: top;
    }

    .table-like th {
      background: #f2f4fb;
      text-align: left;
      font-weight: 600;
      font-size: 0.86rem;
    }

    body.dark .table-like th {
      background: #020617;
    }

    .tag-row {
      display: flex;
      flex-wrap: wrap;
      gap: 0.25rem;
      margin-top: 0.4rem;
    }

    /* TIMELINE: dates big, text lighter, more spacing */
    .timeline {
      border-left: 3px solid var(--accent-soft);
      padding-left: 1.2rem;
      margin-top: 0.8rem;
    }

    .timeline-item {
      margin-bottom: 1.3rem;
      padding: 0.7rem 0.9rem 0.7rem 0;
      border-radius: 12px;
      background: rgba(148, 163, 184, 0.06);
    }

    body.dark .timeline-item {
      background: #020617;
    }

    .timeline-item::before {
      content: "";
      width: 10px;
      height: 10px;
      border-radius: 999px;
      background: var(--accent);
      position: absolute;
      left: -1.35rem;
      top: 0.9rem;
    }

    .timeline-label {
      font-size: 1.05rem;
      font-weight: 700;
      color: var(--accent);
      margin-bottom: 0.3rem;
    }

    .timeline-item p,
    .timeline-item ul {
      font-size: 0.88rem;   /* a bit smaller than main text */
      line-height: 1.7;
    }

    .footer-note {
      text-align: center;
      font-size: 0.8rem;
      color: var(--text-muted);
      margin-top: 1.5rem;
    }

    @media (max-width: 900px) {
      .nav-container {
        flex-direction: column;
        align-items: flex-start;
      }
      .nav-controls {
        margin-left: 0;
      }
      nav.nav-links {
        width: 100%;
      }
    }

    @media (max-width: 768px) {
      .grid-2 {
        grid-template-columns: minmax(0, 1fr);
      }
    }
  /* INTERACTIVE TIMELINE */
.interactive-timeline {
  max-width: 100%;
  margin-top: 1rem;
  position: relative;
  border-left: 4px solid var(--accent);
  padding-left: 1.5rem;
}

.timeline-event {
  position: relative;
  margin-bottom: 1.8rem;
  cursor: pointer;
}

.timeline-dot {
  position: absolute;
  left: -2rem;
  top: 0.2rem;
  width: 1.3rem;
  height: 1.3rem;
  background: var(--accent);
  border-radius: 50%;
  border: 3px solid var(--card-bg);
  box-shadow: 0 0 0 3px var(--accent);
  transition: transform 0.3s ease;
}

.timeline-event.open .timeline-dot {
  transform: scale(1.25);
  background: var(--accent);
}

.timeline-date {
  font-size: 1.2rem;
  font-weight: 700;
  color: var(--accent);
  margin-bottom: 0.3rem;
}

.timeline-title {
  font-size: 1rem;
  font-weight: 600;
  margin-bottom: 0.2rem;
}

.timeline-details {
  font-size: 0.9rem;
  line-height: 1.6;
  max-height: 0;
  overflow: hidden;
  opacity: 0;
  transform: translateY(-4px);
  transition: all 0.35s ease;
}

.timeline-event.open .timeline-details {
  max-height: 600px;
  opacity: 1;
  transform: translateY(0);
}

.timeline-event:hover .timeline-title {
  color: var(--accent);
}
/* Differential table: highlight + hover expansion */
.ddx-table {
  margin-top: 0.6rem;
}

.ddx-table th,
.ddx-table td {
  padding: 0.7rem 0.8rem;
  vertical-align: top;
}

.ddx-table tbody tr {
  cursor: pointer;
  transition: transform 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
}

.ddx-table tbody tr:hover {
  transform: scale(1.01);
  background-color: rgba(250, 250, 210, 0.25);
  box-shadow: 0 4px 10px rgba(15, 23, 42, 0.12);
}

.ddx-table ul {
  margin: 0.25rem 0 0.25rem 1rem;
  padding: 0;
  line-height: 1.6;
}

/* Yellow semi-transparent highlighter */
.hl {
  background-color: rgba(253, 224, 71, 0.55); /* warm yellow, semi-transparent */
  padding: 0 0.12em;
  border-radius: 2px;
}

  </style>

</head>
<body>
  <!-- NAVBAR -->
  <header>
    <div class="nav-container">
      <div class="app-title">
        Vulvar Lesion Case &mdash; Teaching Webapp
      </div>

      <div class="nav-controls">
        <button id="theme-toggle" class="utility-button" type="button">
          Light / Dark
        </button>

        <label class="nav-label">
          Font:
          <select id="font-select" class="nav-select">
            <option value="sans">Sans-serif</option>
            <option value="serif">Serif</option>
            <option value="mono">Monospace</option>
          </select>
        </label>

        <label class="nav-label">
          Size:
          <select id="font-size-select" class="nav-select">
            <option value="small">Small</option>
            <option value="medium" selected>Medium</option>
            <option value="large">Large</option>
          </select>
        </label>

        <button id="print-btn" class="utility-button" type="button">
          Export / Print
        </button>
      </div>

      <nav class="nav-links">
        <button class="nav-button active" data-target="overview">Overview</button>
        <button class="nav-button" data-target="clinical">Clinical</button>
        <button class="nav-button" data-target="differentials">Differentials</button>
        <button class="nav-button" data-target="investigations">Investigations</button>
        <button class="nav-button" data-target="histopathology">Histopathology</button>
        <button class="nav-button" data-target="vulvar-crohns">Vulvar Crohn’s in the Literature</button>
        <button class="nav-button" data-target="treatment-prognosis">VCD Tx & Prognosis</button>
        <button class="nav-button" data-target="vulvar-gpa">Vulvar GPA in the Literature</button>
        <button class="nav-button" data-target="course">Clinical Course</button>
        <button class="nav-button" data-target="learning">Teaching Points</button>
        <button class="nav-button" data-target="patient-perspective">Patient</button>
        <button class="nav-button" data-target="references">References</button>
      </nav>
    </div>
  </header>

  <main>
    <!-- PAGE: OVERVIEW -->
    <section id="overview" class="page active">
      <div class="card">
        <div class="card-header">
          <div class="card-title">Case Overview</div>
          <div class="card-subtitle">Non-identifying summary</div>
        </div>
        <p>
          A 53-year-old perimenopausal woman presents with a 2-month history of
          painful vulvar and perianal ulcers and fissures, with biopsy
          demonstrating necrotizing granulomatous inflammation and negative
          infectious stains, in the setting of dual-positive PR3/MPO ANCA,
          without oral involvement and with gastrointestinal status not yet
          assessed in the current episode.
        </p>
        <div class="tag-row">
          <span class="pill">vulvar &amp; perianal ulcers</span>
          <span class="pill">necrotizing granulomas</span>
          <span class="pill">PR3/MPO ANCA+</span>
          <span class="pill badge-danger">teaching case</span>
        </div>
      </div>

      <div class="card">
        <div class="card-header">
          <div class="card-title">Patient Background</div>
          <div class="card-subtitle">Past history & context</div>
        </div>
        <div class="grid-2">
          <div>
            <h3>Chronic conditions</h3>
            <ul>
              <li>
                Iron deficiency anemia secondary to chronic heavy menstrual
                bleeding; required multiple PRBC transfusions (2022, 2023).
              </li>
              <li>
                Adenomyosis and posterior wall uterine fibroid (~3.5 cm).
              </li>
              <li>
                Supraventricular tachycardia (SVT)
                <br />&gt; Status post SVT ablation (Aug 2024).
              </li>
              <li>
                Primary hyperparathyroidism (right inferior parathyroid adenoma)
                <br />&gt; Status post parathyroidectomy (Sep 2022).
              </li>
              <li>No known drug allergies.</li>
            </ul>

            <h3>Prior infections / inflammatory conditions</h3>
            <ul>
              <li>
                H. pylori gastritis (2022) &rarr; treated with levofloxacin-based
                therapy; eradicated.
              </li>
              <li>
                Chronic endometritis on D&amp;C (Dec 2023)
                &rarr; treated with doxycycline.
              </li>
              <li>
                Pelvic inflammatory disease (PID) (Feb 2024)
                &rarr; treated with metronidazole + cefuroxime.
              </li>
              <li>
                January 2025: nonspecific inflammatory vulvovaginitis with
                maceration and secondary infection, presenting with:
                <ul>
                  <li>Vulvar/perianal white plaques.</li>
                  <li>Superficial labial ulcer.</li>
                  <li>Copious discharge.</li>
                </ul>
                &rarr; Resolved completely within 1 week on clindamycin + Polygynax.
                <br />&rarr; Distinct from later necrotizing granulomatous disease.
              </li>
            </ul>
          </div>

          <div>
            <h3>Gynecologic history</h3>
            <ul>
              <li>
                Long-standing heavy menstrual bleeding (perimenopausal), at times
                severe enough to cause Hb 6.7 g/dL.
              </li>
              <li>
                Heavy bleeding controlled with Aminor (norethisterone) for 6
                months; heavy bleeding recurred after discontinuation.
              </li>
              <li>Perimenopausal; LMP July 2025.</li>
              <li>
                Pap smears:
                <ul>
                  <li>Jan 2025: ASC-US with atypical parakeratosis.</li>
                  <li>Sept 2025: NILM (acute inflammation only).</li>
                </ul>
              </li>
              <li>HPV test: negative (Sept 2025).</li>
            </ul>

            <h3>Gastrointestinal history</h3>
            <ul>
              <li>
                2022: GI work-up for anemia:
                <ul>
                  <li>EGD: mild gastritis; H. pylori detected and treated.</li>
                  <li>Colonoscopy: normal.</li>
                </ul>
              </li>
              <li>
                Colonoscopy planned again in 2025 to evaluate current
                necrotizing granulomatous disease, but not yet completed at the
                time of dermatology assessment.
              </li>
            </ul>

            <h3>Family history</h3>
            <ul>
              <li>Breast cancer in a sister (age 50).</li>
              <li>HCC in a sister.</li>
              <li>Sarcoma in brother.</li> 
            
            </ul>
          </div>
        </div>
      </div>
    </section>

    <!-- PAGE: CLINICAL PRESENTATION -->
    <section id="clinical" class="page">
      <div class="card">
        <div class="card-header">
          <div class="card-title">Clinical Presentation</div>
          <div class="card-subtitle">History & examination</div>
        </div>
        <div class="grid-2">
          <div>
            <h3>Chief complaint</h3>
            <p>
              Referred due to recurrent perianal cysts and abscesses and a
              vaginal/vulvar ulcer, to rule out Crohn’s disease. She reports no
              gastrointestinal symptoms (no rectal bleeding, no change in bowel
              habit) at the time of evaluation.
            </p>

            <h3>History of present illness</h3>
            <p>
              Approximately from June 2025, she developed vulvar pruritus,
              vaginal discharge and dyspareunia, along with recurrent painful
              perineal and vaginal papules and cysts that drained spontaneously
              with yellow, blood-streaked pus. She notes pain with defecation
              during flares but no rectal bleeding. Bowels habits have not
              changed. Her husband is asymptomatic.
            </p>
            <p>
              By late September to early October 2025, she developed painful
              slit-like linear vulvar ulcers and a slit-like intergluteal
              “knife-cut” fissure, along with multiple perianal fissures and
              erosions and foul yellow discharge with pruritus. Pain score was
              at times documented as 0/10 on examination, despite significant
              local discomfort historically.
            </p>
            <p>
              A vaginal/vulvar biopsy taken on 8/10/2025 for the ulcerative
              lesion revealed necrotizing granulomatous inflammation. The
              pathology differential included infection (fungal infection,
              mycobacterial tuberculosis, atypical mycobacteria), autoimmune
              disease and foreign body reaction. Infectious stains including
              PAS and Ziehl–Neelsen were reported as negative, and there was no
              evidence of malignancy.
            </p>
            <p>
              She was admitted under the gynecology team from 22–29 October
              2025 for an infected vulvar ulcer post-biopsy, with a slit-like
              intergluteal fissure and multiple perianal fissures/erosions.
              During admission, she was afebrile, with no rectal bleeding and no
              change in bowel habit.
            </p>
          </div>
          <div>
            <h3>Examination</h3>
            <p>
              At the time of dermatology review, systemic examination was
              documented as unremarkable.
            </p>
            <p>
              Local examination during and after admission showed:
            </p>
            <ul>
              <li>
                Large vulvar ulcer at the biopsy site, with features of
                infection initially and later granulation tissue.
              </li>
              <li>
                Persistent slit-like ulcer/fissure in the intergluteal cleft.
              </li>
              <li>
                Multiple perianal fissures, nodules and erosions.
              </li>
              <li>
                Significant pruritus, foul yellow discharge and pain with
                defecation, but no anal bleeding.
              </li>
            </ul>
            <p class="muted">
              Examination at a later OB-GYN follow-up noted major improvement in
              the vulvar wound with granulation tissue, but symptoms had not
              fully resolved.
            </p>
          </div>
        </div>
      </div>

      <div class="card">
        <div class="card-header">
          <div class="card-title">Clinical Images</div>
          <div class="card-subtitle">Timeline-based placeholders</div>
        </div>
        <p class="muted">
          Replace each placeholder with an <code>&lt;img&gt;</code> tag once
          images are ready, ensuring consent and anonymisation.
        </p>
        <div class="image-grid">
          <div class="image-placeholder">
            Jan 2025: nonspecific inflammatory vulvovaginitis with white plaques
            and superficial ulcer (resolved with antibiotics/Polygynax)
          </div>
          <div class="image-placeholder">
            Jun–Sep 2025: painful draining perineal/vulvar nodules and cysts
            (pre-ulcer stage)
          </div>
          <div class="image-placeholder">
            Late Sep–Oct 2025: vulvar ulcer post-biopsy, knife-cut intergluteal
            fissure, perianal fissures/erosions
          </div>
          <div class="image-placeholder">
            Post-discharge: granulation tissue with residual ulcer and fissures
            prior to systemic steroid/fluconazole trial
          </div>
        </div>
      </div>
    </section>

    <!-- PAGE: DIFFERENTIALS -->
<section id="differentials" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Differential Diagnosis – Granulomatous Vulvar / Perianal Disease</div>
      <div class="card-subtitle">Spacious table with hover expansion</div>
    </div>

    <table class="table-like ddx-table">
      <thead>
        <tr>
          <th>Diagnosis</th>
          <th>Findings in Favor</th>
          <th>Findings Against</th>
          <th>Further Investigation (Rule-In / Rule-Out)</th>
        </tr>
      </thead>
      <tbody>

        <!-- VULVAR / METASTATIC CROHN'S -->
        <tr>
          <td>
            <span class="hl">Vulvar / Metastatic Crohn’s Disease</span>
          </td>
          <td>
            <ul>
              <li><span class="hl">Knife-cut intergluteal fissure</span></li>
              <li><span class="hl">Vulvar + perianal involvement</span></li>
              <li><span class="hl">Non-necrotizing granulomas</span> (matches Crohn’s pattern in literature table)</li>
              <li>Chronic inflammatory course</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>No change in bowel habits</li>
              <li>No diarrhea, abdominal pain, or weight loss</li>
              <li><span class="hl">Dual PR3/MPO ANCA</span> pattern atypical for Crohn’s</li>
              <li>Focal necrosis may be ulcer-related but is unusual for classic Crohn’s granulomas</li>
            </ul>
          </td>
          <td>
            <ul>
              <li><span class="hl">Colonoscopy</span></li>
              <li>Fecal calprotectin</li>
              <li>MRI pelvis (perianal disease assessment)</li>
              <li>Repeat biopsy if needed</li>
              <li>GI consultation</li>
            </ul>
          </td>
        </tr>

        <!-- ATYPICAL MYCOBACTERIAL INFECTION -->
        <tr>
          <td>
            <span class="hl">Atypical Mycobacterial Infection (NTM)</span>
          </td>
          <td>
            <ul>
              <li>Ill-defined granulomas compatible with NTM</li>
              <li>Ulceration and tissue necrosis can mimic inflammatory necrosis</li>
              <li>Chronic nodules and fissures possible</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>AFB stains negative (though sensitivity is limited)</li>
              <li>No systemic “B” symptoms documented</li>
            </ul>
          </td>
          <td>
            <ul>
              <li><span class="hl">AFB culture (essential)</span></li>
              <li>Mycobacterial PCR</li>
              <li>Repeat biopsy for culture/PCR if feasible</li>
              <li>TB QuantiFERON (baseline)</li>
            </ul>
          </td>
        </tr>

        <!-- FOREIGN BODY GRANULOMATOUS REACTION -->
        <tr>
          <td>
            <span class="hl">Foreign-Body Granulomatous Reaction</span>
          </td>
          <td>
            <ul>
              <li><span class="hl">Polarizable foreign material</span> present in multinucleated giant cells</li>
              <li>History of chronic irritation / wound care can contribute</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>Does not explain pattern of widespread granulomas</li>
              <li>Does not explain ANCA positivity</li>
              <li>Does not fully explain ulcer distribution</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>No specific additional testing required</li>
              <li>Considered as a secondary contributor rather than primary diagnosis</li>
            </ul>
          </td>
        </tr>

        <!-- DEEP FUNGAL INFECTION -->
        <tr>
          <td>
            <span class="hl">Deep Fungal Infection</span>
            <br>(Sporothrix, Blastomyces, Histoplasma, etc.)
          </td>
          <td>
            <ul>
              <li>Deep fungi can cause granulomatous inflammation</li>
              <li>Ulceration and chronic plaques possible</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>PAS/GMS stains negative</li>
              <li>No clear travel / environmental exposure documented</li>
              <li>No systemic symptoms</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>Fungal culture</li>
              <li>Fungal PCR</li>
              <li>Serologies if specific exposure is suspected</li>
            </ul>
          </td>
        </tr>

        <!-- SARCOIDOSIS -->
        <tr>
          <td>
            <span class="hl">Sarcoidosis</span>
          </td>
          <td>
            <ul>
              <li>Non-necrotizing granulomas possible in vulvar skin</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>Typical “naked” granulomas not described here</li>
              <li>Ulceration is uncommon</li>
              <li>No pulmonary, ocular, or systemic features documented</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>Chest X-ray or CT</li>
              <li>Serum ACE (low specificity, supportive only)</li>
            </ul>
          </td>
        </tr>

        <!-- GRANULOMATOSIS WITH POLYANGIITIS -->
        <tr>
          <td>
            <span class="hl">Granulomatosis with Polyangiitis (GPA)</span>
          </td>
          <td>
            <ul>
              <li><span class="hl">Dual PR3 + MPO ANCA</span> positivity</li>
              <li>Mucocutaneous ulceration possible in ANCA-associated vasculitis</li>
            </ul>
          </td>
          <td>
            <ul>
              <li><span class="hl">No vasculitis on biopsy</span> in current samples</li>
              <li>Non-necrotizing granulomas not classic GPA pattern in most descriptions</li>
              <li>No ENT, renal, or pulmonary involvement documented so far</li>
            </ul>
          </td>
          <td>
            <ul>
              <li>Repeat ANCA (trend over time)</li>
              <li>Serial urinalysis + creatinine monitoring</li>
              <li>Chest imaging</li>
              <li>ENT evaluation for subclinical disease</li>
              <li>Repeat biopsy only if systemic signs develop</li>
            </ul>
          </td>
        </tr>

      </tbody>
    </table>
  </div>
</section>



    <!-- PAGE: INVESTIGATIONS -->
    <section id="investigations" class="page">
      <div class="card">
        <div class="card-header">
          <div class="card-title">Investigations to Date</div>
          <div class="card-subtitle">During Oct 2025 admission</div>
        </div>

        <h3>Laboratory (rheumatology work-up)</h3>
        <ul>
          <li>ESR: 95.</li>
          <li>CRP (quantitative): 2.22.</li>
          <li>ANA: 1:40, fine speckled.</li>
          <li>ENA panel: negative.</li>
          <li>ANCA:
            <ul>
              <li>MPO: 15.3 (positive).</li>
              <li>PR3: 20 (positive).</li>
            </ul>
          </li>
          <li>HbA<sub>1c</sub>: 6.18%.</li>
        </ul>

        <h3>Microbiology & serology</h3>
        <ul>
          <li>
            Wound culture (initial): Group B Streptococcus and
            coagulase-negative Staphylococcus &rarr; prompted IV ceftriaxone +
            metronidazole, then switch to Augmentin.
          </li>
          <li>Repeat wound culture after IV antibiotics: no growth.</li>
          <li>VDRL: negative.</li>
          <li>HIV: negative.</li>
          <!-- HBsAg / HCV were provided earlier from labs; keep only if you want -->
        </ul>

        <h3>Urinalysis & imaging</h3>
        <ul>
          <li>Urinalysis: no proteinuria, no hematuria.</li>
          <li>Chest X-ray: unremarkable.</li>
        </ul>

        <h3>Endoscopy</h3>
        <ul>
          <li>Colonoscopy 2022: normal (performed for anemia work-up).</li>
          <li>
            Colonoscopy for current necrotizing granulomatous disease: planned
            but not yet performed.
          </li>
          <li>
            EGD 2022: mild gastritis; H. pylori detected and treated
            successfully.
          </li>
        </ul>
      </div>

      <div class="card">
        <div class="card-header">
          <div class="card-title">Outstanding Investigations</div>
          <div class="card-subtitle">Dermatology + Rheumatology + GI plan</div>
        </div>
        <ol>
          <li>
            Repeat infectious work-up (as recommended): mycobacterial culture
            and PCR, deep fungal culture and PCR, and any pending tests from the
            suggested panel.
          </li>
          <li>
            Gastroenterology assessment for Crohn’s disease:
            colonoscopy and fecal calprotectin.
          </li>
          <li>
            Rheumatology follow-up for ANCA-positive necrotizing granulomatous
            disease: further vasculitis assessment (including imaging and serial
            renal monitoring as clinically indicated).
          </li>
          <li>
            Consider re-biopsy from the ulcer edge with specimens sent for
            histology, culture, AFB and fungal stains, and PCR if needed.
          </li>
          <li>Continue wound care and avoid aggressive debridement.</li>
          <li>
            Use systemic steroids cautiously until infection has been
            adequately excluded.
          </li>
        </ol>
      </div>
    </section>

    <!-- PAGE: HISTOPATHOLOGY -->
<section id="histopathology" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Histopathology</div>
      <div class="card-subtitle">Clinical data, macroscopic & microscopic findings</div>
    </div>

    <!-- Clinical Data -->
    <h3>Clinical Data</h3>
    <p>
      Multiple vulvar and white plaques with left vulvar ulcer.
    </p>

    <!-- Macroscopic -->
    <h3>Macroscopic Description</h3>

    <div style="margin-bottom:1.2rem;">
      <p><span style="background:rgba(255,249,196,0.7);">1 – Punch biopsy</span></p>
      <p>
        Specimen fixed in formalin labelled "punch biopsy" and consists of a punch biopsy
        measuring 0.4 × 0.3 × 0.5 (depth) cm.<br>
        Totally submitted in 1 cassette.
      </p>
    </div>

    <div style="margin-bottom:1.2rem;">
      <p><span style="background:rgba(255,249,196,0.7);">2 – Multiple fragments</span></p>
      <p>
        Specimen fixed in formalin labelled with patient's name and consists of multiple fragments
        of grayish tissue measuring in aggregate 1 × 0.5 cm.<br>
        Totally submitted in 1 cassette.
      </p>
    </div>

    <div style="margin-bottom:1.2rem;">
      <p><span style="background:rgba(255,249,196,0.7);">3 – Vulvar biopsy</span></p>
      <p>
        Specimen fixed in formalin labelled "vulvar biopsy" and consists of 2 skin ellipses:
      </p>
      <ul>
        <li>Largest: 4.5 × 1.5 × 0.5 cm</li>
        <li>Second: 1.3 × 0.5 × 0.3 cm</li>
        <li>Additional skin biopsy: 0.6 × 0.5 cm</li>
      </ul>
      <p>
        The deep and periphery of both skin ellipses are inked black.<br><br>
        <span style="background:rgba(255,249,196,0.7);">An ulcer is identified on the largest ellipse</span>
        measuring 2 × 0.5 cm, with eroded skin measuring 0.5 × 0.2 cm.<br>
        This ulcer is:
      </p>
      <ul>
        <li>0.5 cm from the closest peripheral margin</li>
        <li>2 cm from the opposite peripheral margin</li>
      </ul>
      <p><strong>Cassettes:</strong></p>
      <ul>
        <li>A: Skin biopsy</li>
        <li>B: Tips of largest ellipse</li>
        <li>C–E: Center of largest ellipse</li>
        <li>F: Tips of second ellipse</li>
        <li>G: Center of second ellipse</li>
      </ul>
    </div>

    <!-- Microscopic -->
    <h3>Microscopic Description</h3>

    <div style="margin-bottom:1.2rem;">
      <p><span style="background:rgba(255,249,196,0.7);">Specimen 1</span></p>
      <p>
        Sections show chronic active inflammation along with
        <span style="background:rgba(255,249,196,0.7);">necrotizing granulomas</span>
        involving the upper to mid dermis. The infiltrate is lymphoplasmacytic with neutrophils
        and eosinophils.
      </p>
      <p>
        PAS, Gram, Ziehl–Neelsen and Warthin–Starry stains fail to highlight fungal, bacterial,
        acid-fast bacilli or other microorganisms.
      </p>
      <p>
        Overlying epidermis: acanthosis, spongiosis with lymphocytic exocytosis.
      </p>
    </div>

    <div style="margin-bottom:1.2rem;">
      <p><span style="background:rgba(255,249,196,0.7);">Specimen 3</span></p>
      <p>
        Sections show a large ulcer site and chronic active inflammation with
        <span style="background:rgba(255,249,196,0.7);">necrotizing granulomas</span>
        involving the upper to mid dermis. The infiltrate is lymphoplasmacytic with neutrophils
        and multinucleated giant cells
        <span style="background:rgba(255,249,196,0.7);">(some engulfing polarizable foreign body material)</span>,
        along with granulation tissue formation.
      </p>
      <p>
        Few bacterial structures are identified and highlighted by Gram stain.
        PAS, Ziehl–Neelsen and Warthin–Starry stains are negative for fungal, AFB and other microorganisms.
      </p>
      <p>
        Overlying epidermis: acanthosis, spongiosis with lymphocytic exocytosis and neutrophilic exudate.<br>
        No evidence of malignancy.
      </p>
    </div>

    <!-- Diagnosis -->
    <h3>Diagnosis</h3>

    <p><strong>1 – Skin, perineum, punch biopsy:</strong></p>
    <ul>
      <li><span style="background:rgba(255,249,196,0.7);">Necrotizing granulomatous inflammation</span>, see comment.</li>
      <li>No evidence of malignancy.</li>
    </ul>

    <p><strong>2 – Uterus, dilatation and curettage:</strong></p>
    <ul>
      <li>Inactive atrophic endometrium.</li>
      <li>No evidence of endometrial hyperplasia or malignancy.</li>
    </ul>

    <p><strong>3 – Skin, vulva, left, excision:</strong></p>
    <ul>
      <li><span style="background:rgba(255,249,196,0.7);">Necrotizing granulomatous inflammation with ulcer site</span>, see comment.</li>
      <li>No evidence of malignancy.</li>
    </ul>

    <!-- Comment -->
    <h3>Comment</h3>
    <p>
      The differential diagnosis for granulomatous inflammation is wide and can be associated with different
      etiologies including but not limited to:
    </p>
    <ul>
      <li><span style="background:rgba(255,249,196,0.7);">Infectious causes</span> (fungal, mycobacterial tuberculosis, atypical mycobacteria)</li>
      <li><span style="background:rgba(255,249,196,0.7);">Autoimmune diseases</span></li>
      <li><span style="background:rgba(255,249,196,0.7);">Foreign body–type giant cell reaction</span></li>
    </ul>
    <p>Clinical and microbiologic correlation is recommended.</p>

  </div>
</section>


    <!-- PAGE: VULVAR CROHN'S LITERATURE REVIEW -->
<section id="vulvar-crohns" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Vulvar / Anogenital Metastatic Crohn’s Disease</div>
      <div class="card-subtitle">Chronological literature summary</div>
    </div>

    <p class="muted">
      Chronological summary of key studies on vulvar / anogenital metastatic Crohn’s disease, based on the authors’ compiled review.
    </p>

    <table class="table-like">
      <thead>
        <tr>
          <th>Study</th>
          <th>Year</th>
          <th>Type / Sample</th>
          <th>Anatomic involvement</th>
          <th>Histopathology</th>
          <th>Treatment (reported)</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Parks AG et al., Proc R Soc Med<br><span class="muted">(first description of metastatic Crohn’s)</span></td>
          <td>1965</td>
          <td>6 patients</td>
          <td>Cutaneous lesions remote from GI tract; vulvar sites not detailed</td>
          <td>Non-caseating granulomas</td>
          <td>Early corticosteroids; sulfasalazine</td>
        </tr>

        <tr>
          <td>Porzionato et al., J Pediatr Surg</td>
          <td>2005</td>
          <td>Single pediatric case</td>
          <td>Vulvar swelling + perianal fissures</td>
          <td>Non-caseating epithelioid granulomas</td>
          <td>Systemic corticosteroids</td>
        </tr>

        <tr>
          <td>Andreani et al., Int J Surg</td>
          <td>2010</td>
          <td>Review of ~57 reported cases</td>
          <td>Vulvar edema, fissures, ulcers; 30–50% perianal disease; ~30% without GI Crohn’s initially</td>
          <td>Non-caseating granulomas</td>
          <td>Metronidazole; systemic steroids; azathioprine; anti-TNF agents</td>
        </tr>

        <tr>
          <td>Barret et al., J Crohn’s &amp; Colitis<br><span class="muted">(systematic review – 86 cases)</span></td>
          <td>2014</td>
          <td>Systematic review (86 cases)</td>
          <td>67% labial swelling; 40% vulvar ulcers; 48% perianal disease; 25% vulvar-first presentation</td>
          <td>Non-caseating tuberculoid granulomas</td>
          <td>Metronidazole; systemic steroids; azathioprine; anti-TNF; surgery for refractory cases</td>
        </tr>

        <tr>
          <td>Laftah et al., J Crohn’s Colitis</td>
          <td>2015</td>
          <td>22-patient cohort</td>
          <td>36% vulvar disease without intestinal Crohn’s; 41% perianal disease</td>
          <td>Granulomatous inflammation (non-necrotizing)</td>
          <td>Topical/systemic steroids; 57% azathioprine; anti-TNF therapy</td>
        </tr>

        <tr>
          <td>Shields et al., JAAD Case Rep / Review</td>
          <td>2020</td>
          <td>Case series + narrative review</td>
          <td>Knife-cut fissures; vulvar edema; 30–40% perianal involvement</td>
          <td>Non-caseating granulomas</td>
          <td>Antibiotics for superinfection; metronidazole; thiopurines; anti-TNF therapy</td>
        </tr>
      </tbody>
    </table>
  </div>
</section>

<!-- PAGE: TREATMENT & PROGNOSIS OF VULVAR / ANOGENITAL CROHN’S -->
<section id="treatment-prognosis" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Treatment vs Prognosis in Vulvar / Anogenital Crohn’s Disease</div>
      <div class="card-subtitle">Summary of reported effectiveness across case literature</div>
    </div>

    <h3>Treatment (What the literature consistently shows)</h3>

    <h4><strong>First line / frequently effective</strong></h4>
    <ul>
      <li><strong>Metronidazole</strong> – most consistently effective early therapy; may give rapid but partial improvement.</li>
      <li><strong>Topical / intralesional corticosteroids</strong> – symptomatic relief.</li>
      <li><strong>Systemic corticosteroids</strong> – for more severe inflammatory disease.</li>
    </ul>

    <h4><strong>Second-line / for persistent or recurrent disease</strong></h4>
    <ul>
      <li><strong>Azathioprine</strong> (≈57% of patients in Laftah) – for persistent or recurrent disease.</li>
      <li><strong>Methotrexate</strong> – alternative immunomodulator.</li>
    </ul>

    <h4><strong>Biologics</strong></h4>
    <ul>
      <li><strong>Anti-TNF agents (Infliximab, Adalimumab)</strong>
        <ul>
          <li>Highly effective in refractory cases.</li>
          <li>Frequently required for long-term disease control.</li>
        </ul>
      </li>
      <li><strong>Antibiotics</strong> – treat secondary infection only; do not resolve the granulomatous disease.</li>
    </ul>

  </div>

  <div class="card">
    <div class="card-header">
      <div class="card-title">Prognosis</div>
      <div class="card-subtitle">Patterns described across case reports and series</div>
    </div>

    <ul>
      <li>Chronic, relapsing, often refractory course.</li>
      <li><strong>“Vulvar-only Crohn’s”</strong> tends to be more treatment-resistant.</li>
      <li>Better long-term outcomes with early immunomodulators/biologics.</li>
      <li>Delayed diagnosis → worse morbidity, more aggressive disease.</li>
      <li>Risk of future intestinal Crohn’s: <strong>≈30–40%</strong> eventually develop GI involvement.</li>
      <li>Secondary infection (e.g., GBS, Staph) frequently complicates the course.</li>
      <li>Potential for scarring and architectural distortion in chronic disease.</li>
    </ul>
  </div>

</section>
<!-- PAGE: VULVAR GPA LITERATURE -->
<section id="vulvar-gpa" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Vulvar / Gynecologic GPA (ANCA-Associated Vasculitis)</div>
      <div class="card-subtitle">Summary of published cases</div>
    </div>

    <p class="muted">
      Chronological summary of published cases of vulvar or gynecologic involvement in ANCA-associated vasculitis (GPA / EGPA), based strictly on the extracted table. :contentReference[oaicite:1]{index=1}
    </p>

    <table class="table-like">
      <thead>
        <tr>
          <th>Study</th>
          <th>Year</th>
          <th>Type / Sample</th>
          <th>Anatomic involvement</th>
          <th>Histopathology</th>
          <th>Treatment reported</th>
        </tr>
      </thead>

      <tbody>

        <tr>
          <td>Lewis, <em>J Reprod Med</em><br>“Vulvar involvement in Wegener’s granulomatosis”</td>
          <td>2002</td>
          <td>Single case</td>
          <td>Vulva</td>
          <td>Necrotizing granulomatous vasculitis</td>
          <td>Corticosteroids + cyclophosphamide</td>
        </tr>

        <tr>
          <td>Bastone et al., <em>Clin Exp Rheumatol</em></td>
          <td>2015</td>
          <td>Single case</td>
          <td>Cervix &amp; upper vagina</td>
          <td>Necrotizing granulomatous vasculitis</td>
          <td>Rituximab</td>
        </tr>

        <tr>
          <td>Pereira et al., <em>Int J Environ Res Public Health</em><br>Case + review</td>
          <td>2022</td>
          <td>Case + literature review</td>
          <td>Vulva, cervix, uterus</td>
          <td>Necrotizing granulomatous vasculitis; ANCA-positive</td>
          <td>High-dose corticosteroids + rituximab</td>
        </tr>

        <tr>
          <td>Nowak et al., <em>Int J Environ Res Public Health</em><br>“Vulvar involvement mimicking carcinoma”</td>
          <td>2022</td>
          <td>Single case</td>
          <td>Labium minus</td>
          <td>Necrotizing granulomatous vasculitis</td>
          <td>Corticosteroids + cyclophosphamide</td>
        </tr>

        <tr>
          <td>Swain et al., <em>J Pediatr Adolesc Gynecol</em> (EGPA)</td>
          <td>2019</td>
          <td>Pediatric case</td>
          <td>Vulvar granuloma</td>
          <td>Granulomatous vasculitis with eosinophils</td>
          <td>Prednisone → methotrexate → mycophenolate</td>
        </tr>

        <tr>
          <td>Živanović et al., <em>J Pediatr Adolesc Gynecol</em><br>“Extensive vulvar involvement as initial GPA presentation”</td>
          <td>2025</td>
          <td>Single case</td>
          <td>Vulva (necrotic lesions)</td>
          <td>Necrotizing granulomatous vasculitis; PR3-ANCA positive</td>
          <td>Corticosteroids + rituximab</td>
        </tr>

      </tbody>
    </table>
  </div>
</section>

    <!-- PAGE: CLINICAL COURSE -->
<section id="course" class="page">
  <div class="card">
    <div class="card-header">
      <div class="card-title">Clinical Course</div>
      <div class="card-subtitle">Interactive timeline</div>
    </div>

    <div class="interactive-timeline">

      <!-- 2022 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">2022</div>
        <div class="timeline-title">Severe iron deficiency anemia</div>
        <div class="timeline-details">
          ~1-year history of heavy menstrual bleeding causing Hb 6.7 g/dL requiring PRBC transfusions.
          <br><br>
          GI work-up:
          <ul>
            <li>EGD: mild gastritis; H. pylori detected and treated.</li>
            <li>Colonoscopy: normal.</li>
          </ul>
        </div>
      </div>

      <!-- Dec 2023 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">Dec 2023</div>
        <div class="timeline-title">Chronic endometritis</div>
        <div class="timeline-details">
          Diagnosed on D&C → treated with doxycycline.
        </div>
      </div>

      <!-- Feb 2024 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">Feb 2024</div>
        <div class="timeline-title">Pelvic inflammatory disease</div>
        <div class="timeline-details">
          PID with dyspareunia, discharge & pelvic pain → treated with cefuroxime + metronidazole.
          Began norethisterone for heavy menses.
        </div>
      </div>

      <!-- Jan 2025 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">Jan 2025</div>
        <div class="timeline-title">Inflammatory vulvovaginitis (resolved)</div>
        <div class="timeline-details">
          Vulvar/perianal plaques, superficial ulcer, copious discharge → resolved in 1 week on clindamycin + Polygynax.
          <br><br>
          <strong>Distinct from later necrotizing granulomatous disease.</strong>
        </div>
      </div>

      <!-- Jun 2025 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">≈ Jun 2025</div>
        <div class="timeline-title">Onset of chronic anogenital disease</div>
        <div class="timeline-details">
          Gradual onset of pruritus, discharge, dyspareunia, recurrent draining perineal/vaginal nodules.
          Husband asymptomatic.
        </div>
      </div>

      <!-- Sep–Oct 2025 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">Late Sep–Oct 2025</div>
        <div class="timeline-title">Ulceration phase begins</div>
        <div class="timeline-details">
          Painful slit-like vulvar ulcers, “knife-cut” intergluteal fissure, multiple perianal fissures.
          <br><br>
          Biopsy (8/10/2025):
          <ul>
            <li>Necrotizing granulomatous inflammation</li>
            <li>Special stains negative</li>
            <li>No malignancy</li>
          </ul>
        </div>
      </div>

      <!-- 22–29 Oct 2025 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">22–29 Oct 2025</div>
        <div class="timeline-title">Gynecology admission</div>
        <div class="timeline-details">
          Infected vulvar ulcer post-biopsy, fissures, erosions, pruritus, foul discharge.
          <br><br>
          Management:
          <ul>
            <li>IV ceftriaxone + metronidazole</li>
            <li>Daily wound care</li>
            <li>G. B. Strep + CoNS → switched to Augmentin</li>
          </ul>

          Infectious disease:
          <ul>
            <li>VDRL negative</li>
            <li>Atypical mycobacterial/fungal cultures recommended (not done)</li>
            <li>Repeat culture: no growth</li>
          </ul>

          Dermatology:
          <ul>
            <li>Persistent ulcer + fissures</li>
            <li>HIV negative</li>
            <li>Differential: Crohn’s, atypical mycobacteria, fungi, autoimmune, syphilis</li>
          </ul>

          Rheumatology:
          <ul>
            <li>ANA 1:40</li>
            <li>PR3+ / MPO+ ANCA</li>
            <li>ESR 95, CRP 2.22</li>
            <li>UA normal</li>
            <li>CXR unremarkable</li>
          </ul>

          Discharged 29 Oct with Augmentin; colonoscopy pending.
        </div>
      </div>

      <!-- Nov 2025 -->
      <div class="timeline-event">
        <div class="timeline-dot"></div>
        <div class="timeline-date">Early Nov 2025</div>
        <div class="timeline-title">Post-discharge dermatology review</div>
        <div class="timeline-details">
          Findings:
          <ul>
            <li>Persistent vulvar ulceration</li>
            <li>Persistent intergluteal fissure</li>
            <li>Perianal nodules</li>
          </ul>
          Treatment:
          <ul>
            <li>Prednisolone 40 → 20 mg taper</li>
            <li>Fluconazole 300 mg weekly ×2</li>
          </ul>
          Response:
          <ul>
            <li>Partial ulcer improvement</li>
            <li>Pruritus persisted</li>
          </ul>

          GI: colonoscopy planned, not done.  
          Rheum: follow-up pending.
        </div>
      </div>

    </div>

  </div>
</section>


    <!-- PAGE: TEACHING POINTS -->
    <section id="learning" class="page">
      <div class="card">
        <div class="card-header">
          <div class="card-title">Key Learning Points</div>
          <div class="card-subtitle">From this specific case</div>
        </div>
        <ul>
          <li>
            Necrotizing granulomatous inflammation in vulvar/perianal biopsies
            requires a systematic exclusion of infection (including atypical
            mycobacteria and deep fungal infection) even when special stains are
            negative.
          </li>
          <li>
            Chronic anogenital fissures and ulcers with granulomas should raise
            suspicion for metastatic/extraintestinal Crohn’s disease, even in
            patients without gastrointestinal symptoms at presentation.
          </li>
          <li>
            Dual-positive PR3/MPO ANCA in the setting of necrotizing granulomas
            warrants evaluation for granulomatosis with polyangiitis and other
            ANCA-associated vasculitides.
          </li>
          <li>
            Systemic steroids may provide partial symptomatic relief but should
            be used cautiously when infectious causes have not been fully
            excluded.
          </li>
          <li>
            Multidisciplinary collaboration (Dermatology, Gynecology,
            Infectious Disease, Rheumatology, and Gastroenterology) is critical
            in complex vulvar ulcer cases.
          </li>
        </ul>
      </div>
    </section>

    <!-- PAGE: PATIENT PERSPECTIVE -->
    <section id="patient-perspective" class="page">
      <div class="card">
        <div class="card-header">
          <div class="card-title">Patient Perspective</div>
          <div class="card-subtitle">Quality of life & experience</div>
        </div>
        <p class="muted">
          <!-- TODO: Add an anonymised, consented paragraph in your own words describing
               the impact on daily life, intimacy, mobility and emotional wellbeing, if appropriate. -->
        </p>
      </div>

      <div class="card">
        <div class="card-header">
          <div class="card-title">Ethics & Consent</div>
          <div class="card-subtitle">Use of images and clinical details</div>
        </div>
        <p class="muted">
          <!-- TODO: Add a brief statement confirming that the patient provided informed consent
               for the use of clinical information and images for teaching, and that all identifying
               details have been removed. -->
        </p>
      </div>
    </section>

    <!-- PAGE: REFERENCES -->
    <section id="references" class="page">
      <div class="card">
        <div class="card-header">
          <div class="card-title">References</div>
          <div class="card-subtitle">Articles and resources used</div>
        </div>
        <ol class="muted">
          <li>Parks AG et al. Crohn’s disease with cutaneous involvement. Proc R Soc Med. 1965.</li>
          <li>Andreani SM et al. Crohn’s disease of the vulva. Int J Surg. 2010.</li>
          <li>Laftah Z et al. Vulval Crohn’s disease: a clinical study of 22 patients. J Crohn’s Colitis. 2015.</li>
          <li>Barret M et al. Crohn’s disease of the vulva. J Crohn’s Colitis. 2014.</li>
          <li>Madnani NA et al. Isolated Crohn’s disease of the vulva. Indian J Dermatol Venereol Leprol. 2011.</li>
          <li>Wells LE, Cohen D. Delayed diagnosis of vulvar Crohn’s disease in a patient with no gastrointestinal symptoms. Case Rep Dermatol. 2018.</li>
          <li>Kim S et al. Vulvar Crohn’s disease in an adolescent diagnosed after unsuccessful surgical treatment. BMC Women’s Health. 2021.</li>
          <li>Kokkali K et al. Crohn’s disease of the vulva: a case report. Folia Medica. 2021.</li>
          <li>Gupta S et al. Exploring the unusual: vulvar Crohn’s disease with concomitant leukocytoclastic vasculitis. Indian J Dermatol Venereol Leprol. 2024.</li>
        </ol>
        <p class="footer-note">
          This webapp is for educational purposes only and is not a substitute for individual clinical judgment.
        </p>
      </div>
    </section>
  </main>

  <script>
    // --- Navigation between pages ---
    const buttons = document.querySelectorAll(".nav-button");
    const pages = document.querySelectorAll(".page");

    buttons.forEach((btn) => {
      btn.addEventListener("click", () => {
        const targetId = btn.getAttribute("data-target");

        buttons.forEach((b) => b.classList.remove("active"));
        btn.classList.add("active");

        pages.forEach((page) => {
          if (page.id === targetId) {
            page.classList.add("active");
          } else {
            page.classList.remove("active");
          }
        });

        window.scrollTo({ top: 0, behavior: "auto" });
      });
    });

    // --- Theme, font family, font size controls ---
    const themeToggle = document.getElementById("theme-toggle");
    const fontSelect = document.getElementById("font-select");
    const fontSizeSelect = document.getElementById("font-size-select");

    // Load saved preferences
    const savedTheme = localStorage.getItem("vulvarCaseTheme");
    const savedFont = localStorage.getItem("vulvarCaseFontFamily");
    const savedFontSize = localStorage.getItem("vulvarCaseFontSize");

    if (savedTheme === "dark") {
      document.body.classList.add("dark");
    }

    if (savedFont) {
      fontSelect.value = savedFont;
      applyFontFamily(savedFont);
    } else {
      applyFontFamily("sans");
    }

    if (savedFontSize) {
      fontSizeSelect.value = savedFontSize;
      applyFontSize(savedFontSize);
    } else {
      applyFontSize("medium");
    }

    themeToggle.addEventListener("click", () => {
      document.body.classList.toggle("dark");
      const current = document.body.classList.contains("dark") ? "dark" : "light";
      localStorage.setItem("vulvarCaseTheme", current);
    });

    fontSelect.addEventListener("change", () => {
      const val = fontSelect.value;
      applyFontFamily(val);
      localStorage.setItem("vulvarCaseFontFamily", val);
    });

    fontSizeSelect.addEventListener("change", () => {
      const val = fontSizeSelect.value;
      applyFontSize(val);
      localStorage.setItem("vulvarCaseFontSize", val);
    });

    function applyFontFamily(key) {
      let family;
      if (key === "serif") {
        family = 'Georgia, "Times New Roman", serif';
      } else if (key === "mono") {
        family = '"SF Mono", Menlo, Monaco, Consolas, "Courier New", monospace';
      } else {
        family = 'system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif';
      }
      document.documentElement.style.setProperty("--font-family-main", family);
    }

    function applyFontSize(key) {
      let size;
      if (key === "small") {
        size = "15px";
      } else if (key === "large") {
        size = "18px";
      } else {
        size = "16px";
      }
      document.documentElement.style.setProperty("--root-font-size", size);
    }

    // --- Print / PDF export ---
    const printBtn = document.getElementById("print-btn");
    if (printBtn) {
      printBtn.addEventListener("click", () => {
        window.print();
      });
    }
  // --- INTERACTIVE TIMELINE LOGIC ---
document.querySelectorAll(".timeline-event").forEach(event => {
  event.addEventListener("click", () => {
    // close others
    document.querySelectorAll(".timeline-event").forEach(e => {
      if (e !== event) e.classList.remove("open");
    });
    // toggle current
    event.classList.toggle("open");
  });
});

  </script>
</body>
</html>

